<PAGE> 1
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): August 15, 2000
Medicis Pharmaceutical Corporation
-------------------------------------------------------------------------------
(Exact name of Registrant as Specified in Charter)
DELAWARE 0-18443 52-1574808
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
8125 North Hayden Road
Scottsdale, Arizona 85258
-------------------------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number, including area code (602) 808-8800
4343 East Camelback Road
Phoenix, Arizona 85018
-------------------------------------------------------------------------------
(Former Name or Former Address, if Changed Since Last Report)
<PAGE> 2
ITEM 5. OTHER EVENTS
On August 15, 2000, the Registrant entered into a Development, Commercialization
and License Agreement and Supply Agreement, pursuant to which Registrant agreed
to enter into a strategic alliance with Corixa Corporation ("Corixa") regarding
Corixa's psoriasis immunotherapeutic product, PVAC(TM) treatment, upon the
satisfaction of certain closing conditions. A description of the proposed
transaction is contained in the press release attached hereto as Exhibit 99.1
and incorporated herein by reference.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION AND EXHIBITS
A. EXHIBITS
The following exhibits are filed as part of this report.
99.1 - Press release dated August 15, 2000
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf
by the undersigned hereunto duly authorized.
Medicis Pharmaceutical Corporation
/S/ MARK A. PRYGOCKI, SR.
-----------------------------------------
Mark A. Prygocki, Sr.
Chief Financial Officer
Date: August 15, 2000
<PAGE> 3
EXHIBIT INDEX
<TABLE>
<CAPTION>
Exhibit Number Description
-------------- -----------
<S> <C>
99.1 Press Release dated August 15, 2000
</TABLE>
